In re Revance Therapeutics, Inc. Securities Litigation
Case Number:
3:25-cv-00018
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Baker Donelson
- Bramlett Law Offices
- Entwistle & Cappucci
- Holifield & Janich
- Kirkland & Ellis
- Pomerantz LLP
- Riley & Jacobson
- Skadden Arps
- Stranch Jennings
- Wohl & Fruchter
Companies
Sectors & Industries:
-
March 23, 2026
Revance Investors Ink $17M Deal In Take-Private Offer Suit
Dermal fillers company Revance Therapeutics Inc. and two of its executives have agreed to a $17 million settlement to end claims the company hurt investors after the value of a take-private tender offer was negotiated down following allegations that Revance had breached a distribution deal with another company.
-
January 06, 2025
Biotech Co. Revance Faces Suit After Tender Offer Weakens
Biotechnology company Revance Therapeutics Inc. and two of its executives face a proposed investor class action alleging the company hurt investors after the value of a take-private tender offer was negotiated down following allegations that Revance had breached a distribution deal with another company.